Lung Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report by Sample Type, Biomarker, Technology, End-use, Clinical Application, Product, Region, and Segment Forecasts, 2024-2030

The global lung cancer liquid biopsy market size is anticipated to reach USD 2.35 billion by 2030, growing at a CAGR of 13.3% from 2024 to 2030. Liquid biopsies offer a non-invasive alternative to traditional tissue biopsies, enabling earlier detection of lung cancer. The diagnostics industry is moving towards precision medicine, which requires accurate and comprehensive diagnostic tools. Liquid biopsies offer a promising solution for providing information for personalized treatment plans.

Factors such as late detection and high mortality rates result in a decline in the overall survival rate. Lifestyle habits such as cigarette smoking and tobacco exposure are some of the significant risk factors, contributing to approximately 80% of the total lung cancer cases worldwide. According to the World Health Organization (WHO), in 2020, 22.3% of the world’s population consumed tobacco, which constitutes 36.7% of men and 7.8% of the total women. It also states that tobacco causes the deaths of more than 8 million people each year, including an estimated 1.3 million passive smokers.

Companies are launching newer technologies and products to screen lung cancers. For instance, Delfi Diagnostics launched its blood test to screen for lung cancer in October 2023. This increasing number of launches involving newer launches is anticipated to propel the market.

Lung Cancer Liquid Biopsy Market Report Highlights

Based on sample type, the blood sample-based segment dominated the market in 2023. This can be attributed to the non-invasive nature, repeatability, real-time monitoring capabilities, early detection, and cost-effectiveness of this sample type.
Based on biomarker, the circulating nucleic acids segment led the market in 2023 as it can be detected at very low concentrations in blood samples, even when cancer is at an early stage.
Based on technology, the multi-gene-parallel analysis (NGS) segment dominated the market in 2023.
North America dominated the market for lung cancer liquid biopsy in 2023, owing to factors such as the increasing prevalence of lung cancer, changes in lifestyles, advancements in healthcare, and availability of reimbursement policies.
For instance, according to the American Cancer Society Journals, in 2022, approximately 1,918,030 new cancer cases were observed in the U.S., which included approximately 350 deaths each day from lung cancer, the leading cause of cancer death.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Sample Type
1.2.2. Biomarker
1.2.3. Technology
1.2.4. End-use
1.2.5. Clinical Application
1.2.6. Product
1.2.7. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Sample Type Outlook
2.2.2. Biomarker Outlook
2.2.3. Technology Outlook
2.2.4. End-use Outlook
2.2.5. Clinical Application Outlook
2.2.6. Product Outlook
2.3. Competitive Insights

Chapter 3. Lung Cancer Liquid Biopsy Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Lung Cancer Liquid Biopsy Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape

Chapter 4. Lung Cancer Liquid Biopsy Market: Sample Type Estimates & Trend Analysis

4.1. Sample Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Lung Cancer Liquid Biopsy Market by Sample Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Blood Sample Based
4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. Others
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Lung Cancer Liquid Biopsy Market: Biomarker Estimates & Trend Analysis

5.1. Biomarker Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Lung Cancer Liquid Biopsy Market by Biomarker Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Circulating Nucleic Acids
5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. CTC
5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3. Exosomes/Microvesicles
5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.4. Circulating Proteins
5.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Lung Cancer Liquid Biopsy Market: Technology Estimates & Trend Analysis

6.1. Technology Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Lung Cancer Liquid Biopsy Market by Technology Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Multi-gene-parallel Analysis (NGS)
6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Single Gene Analysis (PCR Microarrays)
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Lung Cancer Liquid Biopsy Market: End-use Estimates & Trend Analysis

7.1. End-use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Lung Cancer Liquid Biopsy Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Hospitals and Laboratories
7.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. Specialty Clinics
7.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.3. Academic and Research Centers
7.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.4. Others
7.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Lung Cancer Liquid Biopsy Market: Clinical Application Estimates & Trend Analysis

8.1. Clinical Application Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Lung Cancer Liquid Biopsy Market by Clinical Application Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
8.4.1. Therapy Selection
8.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.4.2. Treatment Monitoring
8.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.4.3. Early Cancer Screening
8.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.4.4. Recurrence Monitoring
8.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.4.5. Others
8.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Lung Cancer Liquid Biopsy Market: Product Estimates & Trend Analysis

9.1. Product Market Share, 2023 & 2030
9.2. Segment Dashboard
9.3. Lung Cancer Liquid Biopsy Market by Product Outlook
9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
9.4.1. Instruments
9.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
9.4.2. Consumables Kits and Reagents
9.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
9.4.3. Software and Services
9.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 10. Lung Cancer Liquid Biopsy Market: Region Estimates & Trend Analysis

10.1. Regional Market Share, 2023 & 2030
10.2. Lung Cancer Liquid Biopsy Market by Region Outlook
10.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
10.3.1. North America
10.3.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.1.2. U.S.
10.3.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.1.3. Canada
10.3.1.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2. Europe
10.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.2. UK
10.3.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.3. Germany
10.3.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.4. France
10.3.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.5. Italy
10.3.2.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.6. Spain
10.3.2.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.7. Denmark
10.3.2.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.8. Sweden
10.3.2.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.2.9. Norway
10.3.2.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.3. Asia-Pacific
10.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.3.2. Japan
10.3.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.3.3. China
10.3.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.3.4. India
10.3.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.3.5. Thailand
10.3.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.3.6. South Korea
10.3.3.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.3.7. Australia
10.3.3.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.4. Latin America
10.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.4.2. Brazil
10.3.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.4.3. Mexico
10.3.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.4.4. Argentina
10.3.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.5. Middle East and Africa
10.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.5.2. South Africa
10.3.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.5.3. Saudi Arabia
10.3.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.5.4. UAE
10.3.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.3.5.5. Kuwait
10.3.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

11.1. Recent Developments & Impact Analysis, by Key Market Participants
11.2. Company/Competition Categorization
11.3. Vendor Landscape
11.3.1. List of Key Distributors and Channel Partners
11.3.2. Key Customers
11.3.3. Key Company Heat Map Analysis, 2023
11.4. Company Profiles
11.4.1. Agilent Technologies Inc.
11.4.1.1. Company Overview
11.4.1.2. Financial Performance
11.4.1.3. Product Benchmarking
11.4.1.4. Strategic Initiatives
11.4.2. Bio-Rad Laboratories, Inc.
11.4.2.1. Company Overview
11.4.2.2. Financial Performance
11.4.2.3. Product Benchmarking
11.4.2.4. Strategic Initiatives
11.4.3. CARDIFF ONCOLOGY, INC.
11.4.3.1. Company Overview
11.4.3.2. Financial Performance
11.4.3.3. Product Benchmarking
11.4.3.4. Strategic Initiatives
11.4.4. CareDx
11.4.4.1. Company Overview
11.4.4.2. Financial Performance
11.4.4.3. Product Benchmarking
11.4.4.4. Strategic Initiatives
11.4.5. Eurofins Scientific
11.4.5.1. Company Overview
11.4.5.2. Financial Performance
11.4.5.3. Product Benchmarking
11.4.5.4. Strategic Initiatives
11.4.6. Exact Sciences Corporation
11.4.6.1. Company Overview
11.4.6.2. Financial Performance
11.4.6.3. Product Benchmarking
11.4.6.4. Strategic Initiatives
11.4.7. F. Hoffmann-La Roche Ltd
11.4.7.1. Company Overview
11.4.7.2. Financial Performance
11.4.7.3. Product Benchmarking
11.4.7.4. Strategic Initiatives
11.4.8. Guardant Health
11.4.8.1. Company Overview
11.4.8.2. Financial Performance
11.4.8.3. Product Benchmarking
11.4.8.4. Strategic Initiatives
11.4.9. Illumina, Inc.
11.4.9.1. Company Overview
11.4.9.2. Financial Performance
11.4.9.3. Product Benchmarking
11.4.9.4. Strategic Initiatives
11.4.10. LungLife AI, Inc.
11.4.10.1. Company Overview
11.4.10.2. Financial Performance
11.4.10.3. Product Benchmarking
11.4.10.4. Strategic Initiatives
11.4.11. Myriad Genetics, Inc.
11.4.11.1. Company Overview
11.4.11.2. Financial Performance
11.4.11.3. Product Benchmarking
11.4.11.4. Strategic Initiatives
11.4.12. Natera, Inc.
11.4.12.1. Company Overview
11.4.12.2. Financial Performance
11.4.12.3. Product Benchmarking
11.4.12.4. Strategic Initiatives
11.4.13. QIAGEN
11.4.13.1. Company Overview
11.4.13.2. Financial Performance
11.4.13.3. Product Benchmarking
11.4.13.4. Strategic Initiatives
11.4.14. Thermo Fisher Scientific Inc.
11.4.14.1. Company Overview
11.4.14.2. Financial Performance
11.4.14.3. Product Benchmarking
11.4.14.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Lung Cancer Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
Table 4 North America Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 5 North America Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 6 North America Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 7 North America Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 8 North America Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 9 North America Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 10 U.S. Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 11 U.S. Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 12 U.S. Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 13 U.S. Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 14 U.S. Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 15 U.S. Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 16 Canada Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 17 Canada Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 18 Canada Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 19 Canada Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 20 Canada Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 21 Canada Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 22 Europe Lung Cancer Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
Table 23 Europe Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 24 Europe Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 25 Europe Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 26 Europe Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 27 Europe Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 28 Europe Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 29 UK Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 30 UK Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 31 UK Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 32 UK Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 33 UK Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 34 UK Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 35 Germany Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 36 Germany Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 37 Germany Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 38 Germany Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 39 Germany Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 40 Germany Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 41 France Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 42 France Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 43 France Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 44 France Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 45 France Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 46 France Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 47 Italy Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 48 Italy Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 49 Italy Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 50 Italy Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 51 Italy Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 52 Italy Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 53 Spain Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 54 Spain Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 55 Spain Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 56 Spain Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 57 Spain Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 58 Spain Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 59 Denmark Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 60 Denmark Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 61 Denmark Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 62 Denmark Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 63 Denmark Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 64 Denmark Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 65 Sweden Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 66 Sweden Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 67 Sweden Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 68 Sweden Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 69 Sweden Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 70 Sweden Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 71 Norway Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 72 Norway Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 73 Norway Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 74 Norway Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 75 Norway Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 76 Norway Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 77 Asia-Pacific Lung Cancer Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
Table 78 Asia-Pacific Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 79 Asia-Pacific Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 80 Asia-Pacific Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 81 Asia-Pacific Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 82 Asia-Pacific Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 83 Asia-Pacific Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 84 Japan Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 85 Japan Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 86 Japan Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 87 Japan Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 88 Japan Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 89 Japan Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 90 China Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 91 China Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 92 China Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 93 China Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 94 China Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 95 China Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 96 India Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 97 India Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 98 India Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 99 India Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 100 India Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 101 India Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 102 Thailand Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 103 Thailand Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 104 Thailand Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 105 Thailand Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 106 Thailand Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 107 Thailand Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 108 South Korea Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 109 South Korea Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 110 South Korea Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 111 South Korea Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 112 South Korea Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 113 South Korea Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 114 Australia Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 115 Australia Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 116 Australia Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 117 Australia Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 118 Australia Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 119 Australia Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 120 Latin America Lung Cancer Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
Table 121 Latin America Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 122 Latin America Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 123 Latin America Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 124 Latin America Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 125 Latin America Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 126 Latin America Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 127 Brazil Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 128 Brazil Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 129 Brazil Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 130 Brazil Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 131 Brazil Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 132 Brazil Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 133 Mexico Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 134 Mexico Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 135 Mexico Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 136 Mexico Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 137 Mexico Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 138 Mexico Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 139 Argentina Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 140 Argentina Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 141 Argentina Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 142 Argentina Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 143 Argentina Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 144 Argentina Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 145 MEA Lung Cancer Liquid Biopsy Market, by Country, 2018-2030 (USD Million)
Table 146 MEA Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 147 MEA Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 148 MEA Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 149 MEA Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 150 MEA Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 151 MEA Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 152 South Africa Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 153 South Africa Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 154 South Africa Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 155 South Africa Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 156 South Africa Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 157 South Africa Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 158 Saudi Arabia Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 159 Saudi Arabia Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 160 Saudi Arabia Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 161 Saudi Arabia Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 162 Saudi Arabia Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 163 Saudi Arabia Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 164 UAE Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 165 UAE Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 166 UAE Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 167 UAE Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 168 UAE Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 169 UAE Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)
Table 170 Kuwait Lung Cancer Liquid Biopsy Market, by Sample Type, 2018-2030 (USD Million)
Table 171 Kuwait Lung Cancer Liquid Biopsy Market, by Biomarker, 2018-2030 (USD Million)
Table 172 Kuwait Lung Cancer Liquid Biopsy Market, by Technology, 2018-2030 (USD Million)
Table 173 Kuwait Lung Cancer Liquid Biopsy Market, by End-use, 2018-2030 (USD Million)
Table 174 Kuwait Lung Cancer Liquid Biopsy Market, by Clinical Application, 2018-2030 (USD Million)
Table 175 Kuwait Lung Cancer Liquid Biopsy Market, by Product, 2018-2030 (USD Million)

List of Figures

Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 Lung Cancer Liquid Biopsy Market: Market Outlook
Figure 9 Lung Cancer Liquid Biopsy Market Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 Lung Cancer Liquid Biopsy Market Driver Impact
Figure 14 Lung Cancer Liquid Biopsy Market Restraint Impact
Figure 15 Lung Cancer Liquid Biopsy Market: Sample Type Movement Analysis
Figure 16 Lung Cancer Liquid Biopsy Market: Sample Type Outlook and Key Takeaways
Figure 17 Blood Sample-based Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 18 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 19 Lung Cancer Liquid Biopsy Market: Biomarker Movement Analysis
Figure 20 Lung Cancer Liquid Biopsy Market: Biomarker Outlook and Key Takeaways
Figure 21 Circulating Nucleic Acids Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 CTC Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Exosomes/microvesicles Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Circulating Proteins Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Lung Cancer Liquid Biopsy Market: Technology Movement Analysis
Figure 26 Lung Cancer Liquid Biopsy Market: Technology Outlook and Key Takeaways
Figure 27 Multi-gene-parallel Analysis (NGS) Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Single Gene Analysis (PCR Microarrays) Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 Lung Cancer Liquid Biopsy Market: End-use Movement Analysis
Figure 30 Lung Cancer Liquid Biopsy Market: End-use Outlook and Key Takeaways
Figure 31 Hospitals and Laboratories Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Specialty Clinics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Academic and Research Centers Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Lung Cancer Liquid Biopsy Market: Clinical Application Movement Analysis
Figure 36 Lung Cancer Liquid Biopsy Market: Clinical Application Outlook and Key Takeaways
Figure 37 Therapy Selection Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Treatment Monitoring Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Early Cancer Screening Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Recurrence Monitoring Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Lung Cancer Liquid Biopsy Market: Product Movement Analysis
Figure 43 Lung Cancer Liquid Biopsy Market: Product Outlook and Key Takeaways
Figure 44 Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Consumables Kits and Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Software and Services Market Estimates and Forecasts, 2018-2030 (USD Million)

Companies Mentioned

Agilent Technologies Inc.
Bio-Rad Laboratories, Inc.
CARDIFF ONCOLOGY, INC.
CareDx
Eurofins Scientific
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd
Guardant Health
Illumina, Inc.
LungLife AI, Inc.
Myriad Genetics, Inc.
Natera, Inc.
QIAGEN
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	120
Published	May 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 966.5 Million
Forecasted Market Value ( USD ) by 2030	$ 2350 Million
Compound Annual Growth Rate	13.3%
Regions Covered	Global
No. of Companies Mentioned	14

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5813EUR$5,950USD£4,853GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6790EUR$6,950USD£5,669GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8745EUR$8,950USD£7,300GBP

Lung Cancer Liquid Biopsy Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Liquid Biopsy Market by Biomarkers, Sample, Type, Technology, Indication, End-User, Application - Global Forecast 2025-2030

Liquid Biopsy Market Size, Share & Trends Analysis Report by Biomarker (Exosomes, CTC), Application (Cancer, Reproductive Health), Technology, Sample Type, Clinical Application, End-use, Product, Region, and Segment Forecasts, 2024-2030

Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast, Prostate), Non-cancer (NIPT, Infectious)), Sample Type (Blood) - Forecast to 2029

Global Liquid Biopsy Market 2018-2035: Distribution by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-users, Stage of Development, Type of Product, Type of Technique, Application Area and Key Geographical Regions

Liquid Biopsy Market Report by Product And Service, Circulating Biomarker, Cancer Type, End User, and Region 2024-2032